Companies / AEYE Health, Inc.
AEYE Health, Inc.
United States
AEYE Health, Inc. develops and provides autonomous diagnostic screening solutions for diabetic retinopathy and other diseases using AI technology and retinal images.
AEYE Health, Inc., based in United States, has 2 investors on file, among them BioLight Life Sciences and OurCrowd. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Investor | |
| Portfolio page | Venture capital |
More from BioLight Life Sciences
9 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See BioLight Life Sciences' full profile · Who invests alongside it
More from OurCrowd
220 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (28%), Healthcare & Biotech (13%), Cybersecurity (9%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get AEYE Health, Inc. and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when BioLight Life Sciences adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/aeyehealth.com/investors
# also
GET /v1/companies/aeyehealth.com
GET /v1/companies/aeyehealth.com/news